Dementia and risk of adverse warfarin-related events in the nursing home setting
- PMID: 23063288
- DOI: 10.1016/j.amjopharm.2012.09.003
Dementia and risk of adverse warfarin-related events in the nursing home setting
Abstract
Background: Little attention has been focused on the safety of medications administered to treat non illnesses in nursing home residents with dementia. It is unclear whether this population is at increased risk of adverse drug events.
Objectives: To test the hypotheses that in nursing home residents with dementia prescribed warfarin have less time in therapeutic range and a higher incidence of nonpreventable and preventable adverse warfarin events compared to nursing home residents without dementia after controlling for facility and patient characteristics.
Methods: A prospective cohort embedded in a clinical trial of nursing home residents prescribed warfarin in 26 nursing homes in Connecticut was observed for up to 12 months. The primary outcome measures included adverse warfarin events (AWEs) (injuries resulting from warfarin use), potential AWEs (INR [international normalized ratio] >4.5 and management error), and AWE preventability based on physician reviews of medical record abstractions. Potential confounders included nursing home structural characteristics (eg, number of beds and for-profit status), nursing staff time, and nursing home regulatory deficiencies (pharmacy, administrative, quality of care, and all other deficiencies). Multivariable Poisson regression analysis was used to determine the independent association of dementia with potential and preventable AWEs using generalized estimating equations to account for clustering within nursing homes.
Results: Residents with dementia had no difference in the number of INR monitoring tests or percentage of days in the therapeutic range, but did have an increased risk of AWEs (adjusted incidence rate ratio [IRR], 1.47; 95% confidence interval [CI], 1.20-1.82), and preventable or potential AWEs (adjusted IRR, 1.36; 95% CI, 1.06-1.76) after adjustment for patient characteristics, nursing home quality, and case mix. Greater nursing staff time was protective for preventable and potential AWEs (adjusted IRR, 0.66; 95% CI, 0.48-0.90) but not for nonpreventable AWEs.
Conclusion: A diagnosis of dementia was associated with increased risk of nonpreventable and preventable or potential AWEs. Greater nursing staff time was associated with lower risk of preventable AWEs. These findings have implications for quality-of-care reporting and patient safety.
Copyright © 2012 Elsevier HS Journals, Inc. All rights reserved.
Similar articles
-
The safety of warfarin therapy in the nursing home setting.Am J Med. 2007 Jun;120(6):539-44. doi: 10.1016/j.amjmed.2006.07.045. Epub 2007 Apr 26. Am J Med. 2007. PMID: 17524757
-
Randomized trial of a warfarin communication protocol for nursing homes: an SBAR-based approach.Am J Med. 2011 Feb;124(2):179.e1-7. doi: 10.1016/j.amjmed.2010.09.017. Am J Med. 2011. PMID: 21295198 Free PMC article. Clinical Trial.
-
A team-based approach to warfarin management in long term care: a feasibility study of the MEDeINR electronic decision support system.BMC Geriatr. 2010 Jun 10;10:38. doi: 10.1186/1471-2318-10-38. BMC Geriatr. 2010. PMID: 20537178 Free PMC article.
-
Epidemiology of medication-related adverse events in nursing homes.Am J Geriatr Pharmacother. 2006 Sep;4(3):264-72. doi: 10.1016/j.amjopharm.2006.09.011. Am J Geriatr Pharmacother. 2006. PMID: 17062328 Review.
-
Professional, structural and organisational interventions in primary care for reducing medication errors.Cochrane Database Syst Rev. 2017 Oct 4;10(10):CD003942. doi: 10.1002/14651858.CD003942.pub3. Cochrane Database Syst Rev. 2017. PMID: 28977687 Free PMC article. Review.
Cited by
-
Anticipating and Mitigating the Impact of the COVID-19 Pandemic on Alzheimer's Disease and Related Dementias.Am J Geriatr Psychiatry. 2020 Jul;28(7):712-721. doi: 10.1016/j.jagp.2020.04.010. Epub 2020 Apr 18. Am J Geriatr Psychiatry. 2020. PMID: 32331845 Free PMC article.
-
Comparing Outcomes Between Thiazide Diuretics and Other First-line Antihypertensive Drugs in Long-term Nursing Home Residents.Clin Ther. 2020 Apr;42(4):583-591. doi: 10.1016/j.clinthera.2020.02.016. Epub 2020 Mar 27. Clin Ther. 2020. PMID: 32229030 Free PMC article.
-
Hypertension Treatment in US Long-Term Nursing Home Residents With and Without Dementia.J Am Geriatr Soc. 2019 Oct;67(10):2058-2064. doi: 10.1111/jgs.16081. Epub 2019 Jul 22. J Am Geriatr Soc. 2019. PMID: 31328791 Free PMC article.
-
Efficacy of Warfarin Anticoagulation and Incident Dementia in a Community-Based Cohort of Atrial Fibrillation.Mayo Clin Proc. 2018 Feb;93(2):145-154. doi: 10.1016/j.mayocp.2017.09.021. Epub 2018 Jan 9. Mayo Clin Proc. 2018. PMID: 29329798 Free PMC article.
-
Appropriateness of Oral Anticoagulants for the Long-Term Treatment of Atrial Fibrillation in Older People: Results of an Evidence-Based Review and International Consensus Validation Process (OAC-FORTA 2016).Drugs Aging. 2017 Jul;34(7):499-507. doi: 10.1007/s40266-017-0466-6. Drugs Aging. 2017. PMID: 28493216 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
